From recently posted article...! According to a
Post# of 15624
According to a report published by Arcview Market Research, legal cannabis sales in North America totaled $6.7 billion in 2016, up 34 percent from 2015. Sales are projected to reach $22.6 billion by 2021, with a compound annual growth rate of 27 percent. Growing adoption of cannabis by individual consumers is one of the pivotal factors which drives the growth in the market. According to the data from National pollster Gallup, support for nationwide legalization of cannabis was 60% in a 2016 poll, up from 25% in 1995. Cannabis for medical purposes is now legal in 28 states, while 8 states have legalized recreational cannabis. SinglePoint, Inc. (OTC: SING), American Cannabis Company, Inc. (OTC: AMMJ), OWC Pharmaceutical Research Corp. (OTC: OWCP), Lexaria Bioscience Corp. (OTC: LXRP), Terra Tech Corp. (OTC: TRTC).....
....
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. On March 21st, the company announced the highly promising results of its topical cream efficacy tests following months of study and scientific analysis. As a result of the promising results of its psoriasis tests, company's Chairman and CEO, Mr. Mordechai Bignitz, has directed OWC's scientific team to submit an operating plan within 60 to 90 days to conduct double-blind efficacy tests of its cannabinoid-based topical cream on other skin disorders and conditions.
OWCP!!!
http://www.prnewswire.com/news-releases/legal...08253.html